From June 27, 2024 to June 30, 2024, the company has repurchased 655,200 shares, representing 0.1% for CNY 3.02 million. With this, the company has completed the repurchase of 655,200 shares, representing 0.1% for CNY 3.02 million under the buyback announced on June 28, 2024.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.55 CNY | -0.87% |
|
+0.89% | -51.28% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.28% | 406M | |
-6.66% | 12.28B | |
+94.21% | 8.54B | |
-22.14% | 6.58B | |
+8.86% | 5.77B | |
-23.82% | 3.48B | |
+5.12% | 2.54B | |
+43.21% | 2.41B | |
-7.24% | 2.3B | |
-66.31% | 2.07B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on June 28, 2024.